| Abnormal blood–brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI SP Cramer, H Simonsen, JL Frederiksen, E Rostrup, HBW Larsson NeuroImage: Clinical 4, 182-189, 2014 | 202 | 2014 |
| Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study M Filippi, P Preziosa, A Meani, O Ciccarelli, S Mesaros, A Rovira, ... The Lancet Neurology 17 (2), 133-142, 2018 | 118 | 2018 |
| Accurate Determination of Blood–Brain Barrier Permeability Using Dynamic Contrast-Enhanced T1-Weighted MRI: A Simulation and in vivo Study on Healthy … SP Cramer, HBW Larsson Journal of Cerebral Blood Flow & Metabolism 34 (10), 1655-1665, 2014 | 118 | 2014 |
| Increased brainstem perfusion, but no blood-brain barrier disruption, during attacks of migraine with aura A Hougaard, FM Amin, CE Christensen, S Younis, F Wolfram, SP Cramer, ... Brain 140 (6), 1633-1642, 2017 | 102 | 2017 |
| Permeability of the blood–brain barrier predicts conversion from optic neuritis to multiple sclerosis SP Cramer, S Modvig, HJ Simonsen, JL Frederiksen, HBW Larsson Brain 138 (9), 2571-2583, 2015 | 83 | 2015 |
| Relationship between cerebrospinal fluid biomarkers for inflammation, demyelination and neurodegeneration in acute optic neuritis S Modvig, M Degn, H Horwitz, SP Cramer, HBW Larsson, B Wanscher, ... PloS one 8 (10), e77163, 2013 | 67 | 2013 |
| Intact blood− brain barrier during spontaneous attacks of migraine without aura: a 3T DCEMRI study FM Amin, A Hougaard, SP Cramer, CE Christensen, F Wolfram, ... European journal of neurology 24 (9), 1116-1124, 2017 | 55 | 2017 |
| Blood–brain barrier permeability measured using dynamic contrastenhanced magnetic resonance imaging: a validation study A Varatharaj, M Liljeroth, A Darekar, HBW Larsson, I Galea, SP Cramer The Journal of physiology 597 (3), 699-709, 2019 | 43 | 2019 |
| Performance of the 2017 and 2010 revised McDonald criteria in predicting MS diagnosis after a clinically isolated syndrome: a MAGNIMS study M Filippi, P Preziosa, A Meani, G Dalla Costa, S Mesaros, J Drulovic, ... Neurology 98 (1), e1-e14, 2022 | 16 | 2022 |
| Permeability of the blood–brain barrier predicts no evidence of disease activity at 2 years after natalizumab or fingolimod treatment in relapsing–remitting multiple sclerosis SP Cramer, HJ Simonsen, A Varatharaj, I Galea, JL Frederiksen, ... Annals of Neurology 83 (5), 902-914, 2018 | 13 | 2018 |
| Brain capillary transit time heterogeneity in healthy volunteers measured by dynamic contrastenhanced T1weighted perfusion MRI HBW Larsson, MB Vestergaard, U Lindberg, HK Iversen, SP Cramer Journal of Magnetic Resonance Imaging 45 (6), 1809-1820, 2017 | 12 | 2017 |
| Systemic inflammation and blood–brain barrier abnormality in relapsing–remitting multiple sclerosis A Varatharaj, M Liljeroth, S Cramer, C Stuart, E Zotova, A Darekar, ... The Lancet 389, S96, 2017 | 11 | 2017 |
| Blood-brain barrier permeability changes in the first year after alemtuzumab treatment predict 2-year outcomes in relapsing-remitting multiple sclerosis MH Knudsen, U Lindberg, JL Frederiksen, MB Vestergaard, HJ Simonsen, ... Multiple Sclerosis and Related Disorders 63, 103891, 2022 | 4 | 2022 |
| Reproducibility and Optimal Arterial Input Function Selection in Dynamic ContrastEnhanced Perfusion MRI in the Healthy Brain SP Cramer, HBW Larsson, MH Knudsen, HJ Simonsen, MB Vestergaard, ... Journal of Magnetic Resonance Imaging 57 (4), 1229-1240, 2023 | 2 | 2023 |
| Capillary transit time heterogeneity inhibits cerebral oxygen metabolism in patients with reduced cerebrovascular reserve capacity from steno-occlusive disease MB Vestergaard, HK Iversen, SA Simonsen, U Lindberg, SP Cramer, ... Journal of Cerebral Blood Flow & Metabolism 43 (3), 460-475, 2023 | 2 | 2023 |
| Zonulin and blood-brain barrier permeability are dissociated in humans CM Stuart, A Varatharaj, ME Winberg, P Galea, HBW Larsson, SP Cramer, ... Clinical and Translational Medicine 12 (7), e965, 2022 | 2 | 2022 |
| Assessment of Artificial Intelligence Automatic Multiple Sclerosis Lesion Delineation Tool for Clinical Use AM Hindsholm, SP Cramer, HJ Simonsen, JL Frederiksen, F Andersen, ... Clinical Neuroradiology, 1-11, 2022 | 1 | 2022 |
| Cerebrovascular Reactivity and Neurovascular Coupling in Multiple Sclerosis—A Systematic Review MB Vestergaard, JL Frederiksen, HBW Larsson, SP Cramer Frontiers in Neurology 13, 1088, 2022 | 1 | 2022 |
| Permeability of the blood-brain barrier in normal appearing white and grey matter predicts early inadequate treatment response to fingolimod og natalizumab SP Cramer, HJ Simonsen, JL Frederiksen, HBW Larsson MULTIPLE SCLEROSIS JOURNAL 22, 669-670, 2016 | 1 | 2016 |
| Scanner agnostic large-scale evaluation of MS lesion delineation tool for clinical MRI AM Hindsholm, FL Andersen, SP Cramer, HJ Simonsen, MG Askløf, ... Frontiers in Neuroscience 17, 2023 | | 2023 |
